The profound effects of BA6b9 treatment on collagen accumulation and the upregulation of α-SMA, the SK4 channel, and NLRP3 in the atrial epicardium also strengthens the clinical relevance of targeting AF by blocking SK4 K+ channel activity. This evidence concerns the gene KCNN4 and atrial fibrillation.